Drugs / Hepatitis B adjuvanted vaccine
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00383591 | Mar 2002 → Jan 2004 | hepatitis B virus infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00383227 | Dec 1999 → Nov 2000 | hepatitis B virus infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00383383 | Dec 1999 → ? | hepatitis B virus infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hepatitis B adjuvanted vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00383383 ↗ |
| Modality | Vaccine | “New Adjuvanted Hepatitis B Vaccine” NCT00383227 ↗ |